Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 454,000 | 511,000 | 802,000 | 834,000 | 938,000 | -- |
| General And Administrative Expense | 454,000 | 511,000 | 802,000 | 814,000 | 938,000 | -- |
| Other Operating Expenses | -- | 48,000 | -- | -- | -- | -- |
| Operating Expense | 454,000 | 559,000 | 802,000 | 834,000 | 938,000 | -- |
| Operating Income | -454,000 | -559,000 | -802,000 | -834,000 | -938,000 | -- |
| EBIT | -669,000 | -655,000 | -828,000 | -8.8M | -1.1M | -- |
| Interest Expense | 2,000 | 1,000 | 21,000 | 20,000 | 0.00 | -- |
| Interest Expense Non Operating | 2,000 | 1,000 | 21,000 | 20,000 | 0.00 | -- |
| Interest Income | 2,000 | 0.00 | 7,000 | 18,000 | 31,000 | -- |
| Interest Income Non Operating | 2,000 | 0.00 | 7,000 | 18,000 | 31,000 | -- |
| Net Interest Income | 0.00 | -1,000 | -14,000 | -2,000 | 31,000 | -- |
| Other Income Expense | -217,000 | -96,000 | -33,000 | -8.0M | -219,000 | -- |
| Special Income Charges | -92,000 | -84,000 | -19,000 | -8.0M | -206,000 | -- |
| Restructuring And Mergern Acquisition | 92,000 | 84,000 | 19,000 | -186,000 | 206,000 | -- |
| Gain On Sale Of Security | -113,000 | 1,000 | -3,000 | -8,000 | -6,000 | -- |
| Earnings From Equity Interest | -12,000 | -13,000 | -11,000 | -23,000 | -7,000 | -- |
| Pretax Income | -671,000 | -656,000 | -849,000 | -8.9M | -1.1M | -- |
| Tax Provision | -31,000 | -14,000 | -53,000 | -325,000 | 119,000 | -- |
| Tax Effect Of Unusual Items | -9,471 | -1,771 | -1,373 | -293,487 | -31,800 | -- |
| Net Income From Continuing And Discontinued Operation | 2.1M | -9.0M | -796,000 | -8.5M | -1.4M | -- |
| Net Income From Continuing Operation Net Minority Interest | -640,000 | -642,000 | -796,000 | -8.5M | -1.2M | -- |
| Net Income Including Noncontrolling Interests | 2.1M | -9.0M | -796,000 | -8.5M | -1.4M | -- |
| Net Income Common Stockholders | 2.1M | -9.0M | -796,000 | -8.5M | -1.4M | -- |
| Net Income | 2.1M | -9.0M | -796,000 | -8.5M | -1.4M | -- |
| EBITDA | -669,000 | -655,000 | -828,000 | -8.8M | -1.1M | -- |
| Normalized EBITDA | -464,000 | -572,000 | -806,000 | -839,000 | -914,000 | -- |
| Basic EPS | 0.01 | -0.03 | 0.00 | -- | -0.01 | 0.00 |
| Diluted EPS | 0.01 | -0.03 | 0.00 | -- | -0.01 | 0.00 |
| Basic Average Shares | 290.3M | 283.9M | 283.9M | -- | 270.3M | 243.6M |
| Diluted Average Shares | 290.3M | 283.9M | 283.9M | -- | 270.3M | 243.6M |
| Total Unusual Items | -205,000 | -83,000 | -22,000 | -8.0M | -212,000 | -- |
| Total Unusual Items Excluding Goodwill | -205,000 | -83,000 | -22,000 | -8.0M | -212,000 | -- |
| Tax Rate For Calcs | 0.05 | 0.02 | 0.06 | 0.04 | 0.15 | -- |
| Normalized Income | -444,471 | -560,771 | -775,373 | -827,487 | -1.1M | -- |
| Diluted NI Availto Com Stockholders | 2.1M | -9.0M | -796,000 | -8.5M | -1.4M | -- |
| Net Income Continuous Operations | -640,000 | -642,000 | -796,000 | -8.5M | -1.2M | -- |
| Net Income Discontinuous Operations | 2.7M | -8.3M | -- | -- | -109,000 | -28,000 |
| Net Non Operating Interest Income Expense | 0.00 | -1,000 | -14,000 | -2,000 | 31,000 | -- |
| Other Gand A | 454,000 | 511,000 | 779,000 | 791,000 | 938,000 | -- |
| Salaries And Wages | -- | -- | 23,000 | 23,000 | 0.00 | 0.00 |
| Selling And Marketing Expense | -- | -- | 0.00 | 20,000 | -- | -- |
| Total Expenses | 454,000 | 559,000 | 802,000 | 834,000 | 938,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 351,000 | 808,000 | 1.1M | 1.7M | 3.7M | -- |
| Cash Cash Equivalents And Short Term Investments | 351,000 | 808,000 | 1.1M | 1.7M | 3.7M | -- |
| Other Current Assets | 73,000 | 368,000 | 162,000 | 141,000 | 135,000 | -- |
| Current Assets | 424,000 | 5.5M | 1.2M | 1.9M | 3.8M | -- |
| Net PPE | 18.0M | 17.9M | 29.3M | 27.9M | 38.4M | -- |
| Investments And Advances | 5.8M | 4.7M | 4.6M | 4.4M | 4.5M | -- |
| Long Term Equity Investment | 5.8M | 4.7M | 4.6M | 4.4M | 4.5M | -- |
| Other Non Current Assets | 1.9M | 1.8M | 1.8M | 32,000 | 1.7M | -- |
| Total Non Current Assets | 25.9M | 24.6M | 35.9M | 34.3M | 44.6M | -- |
| Total Assets | 26.4M | 30.1M | 37.1M | 36.2M | 48.4M | -- |
| Payables And Accrued Expenses | 1.4M | 2.5M | 1.4M | 1.2M | 1.2M | -- |
| Current Deferred Revenue | 1.2M | 1.8M | 1.7M | 1.7M | 1.9M | -- |
| Other Current Liabilities | -- | 3.1M | -- | -- | -- | -- |
| Current Liabilities | 2.5M | 7.4M | 3.1M | 2.9M | 3.1M | -- |
| Other Non Current Liabilities | -- | 1.9M | 1.9M | 1.9M | 4.3M | 4.3M |
| Total Non Current Liabilities Net Minority Interest | 4.1M | 5.9M | 8.6M | 8.3M | 11.4M | -- |
| Total Liabilities Net Minority Interest | 6.6M | 13.3M | 11.7M | 11.2M | 14.5M | -- |
| Common Stock | 50.4M | 49.3M | 49.3M | 49.3M | 49.3M | -- |
| Capital Stock | 50.4M | 49.3M | 49.3M | 49.3M | 49.3M | -- |
| Retained Earnings | -37.5M | -39.6M | -30.6M | -29.8M | -21.3M | -- |
| Gains Losses Not Affecting Retained Earnings | 6.8M | 7.1M | 6.7M | 5.5M | 5.8M | -- |
| Other Equity Adjustments | 6.8M | 7.1M | 6.7M | 5.5M | 5.8M | -- |
| Common Stock Equity | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Stockholders Equity | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Total Equity Gross Minority Interest | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Total Capitalization | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Net Tangible Assets | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Tangible Book Value | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Working Capital | -2.1M | -1.9M | -1.9M | -1.0M | 709,000 | -- |
| Invested Capital | 19.8M | 16.8M | 25.4M | 25.0M | 33.9M | -- |
| Share Issued | 307.9M | 283.9M | 283.9M | 283.9M | 283.9M | -- |
| Ordinary Shares Number | 307.9M | 283.9M | 283.9M | 283.9M | 283.9M | -- |
| Assets Held For Sale Current | -- | 4.3M | -- | -- | -- | -- |
| Current Deferred Liabilities | 1.2M | 1.8M | 1.7M | 1.7M | 1.9M | -- |
| Financial Assets | 157,000 | -- | -- | -- | -- | -- |
| Investmentsin Associatesat Cost | 5.8M | 4.7M | 4.6M | 4.4M | 4.5M | -- |
| Long Term Provisions | 93,000 | 90,000 | 652,000 | 602,000 | 556,000 | -- |
| Non Current Accounts Receivable | 160,000 | 157,000 | 201,000 | 193,000 | -- | -- |
| Non Current Deferred Liabilities | 4.0M | 3.9M | 6.0M | 5.8M | 6.5M | -- |
| Non Current Deferred Taxes Liabilities | 4.0M | 3.9M | 6.0M | 5.8M | 6.5M | -- |
| Non Current Prepaid Assets | -- | -- | -- | 1.7M | -- | 1.7M |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.6M | 4,000 | -644,000 | -1.1M | -1.2M | -- |
| Cash Flow From Continuing Operating Activities | -1.6M | 123,000 | -644,000 | -1.1M | -1.1M | -- |
| Stock Based Compensation | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -31,000 | 11,000 | -53,000 | -325,000 | 119,000 | -- |
| Deferred Income Tax | -31,000 | 11,000 | -53,000 | -325,000 | 119,000 | -- |
| Change In Working Capital | -1.2M | 581,000 | 154,000 | -239,000 | -340,000 | -- |
| Change In Payables And Accrued Expense | -1.4M | 786,000 | 172,000 | -184,000 | -427,000 | -- |
| Change In Other Current Assets | 285,000 | -205,000 | -18,000 | -55,000 | 87,000 | -- |
| Other Non Cash Items | 94,000 | 113,000 | 40,000 | -166,000 | 391,000 | -- |
| Capital Expenditure | -- | -449,000 | -77,000 | -870,000 | -140,000 | -1.1M |
| Purchase Of PPE | -- | -449,000 | -77,000 | -870,000 | -140,000 | -1.1M |
| Net PPE Purchase And Sale | -- | -449,000 | -77,000 | -870,000 | -140,000 | -1.1M |
| Purchase Of Business | -1.5M | 0.00 | 0.00 | -1.4M | -759,000 | -- |
| Sale Of Investment | 348,000 | -- | -- | -- | 754,000 | -- |
| Net Investment Purchase And Sale | 348,000 | -- | -- | -- | 754,000 | -- |
| Investing Cash Flow | 19,000 | -263,000 | -77,000 | -908,000 | -126,000 | -- |
| Cash Flow From Continuing Investing Activities | 29,000 | -172,000 | -77,000 | -908,000 | -126,000 | -- |
| Repayment Of Debt | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -- | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance Of Capital Stock | -- | -- | -- | 0.00 | 4.3M | -- |
| Net Common Stock Issuance | -- | -- | -- | 0.00 | 4.3M | -- |
| Financing Cash Flow | 1.2M | -- | -- | 0.00 | 4.3M | 100,000 |
| Cash Flow From Continuing Financing Activities | 1.2M | -- | -- | 0.00 | 4.3M | 100,000 |
| Effect Of Exchange Rate Changes | -28,000 | 22,000 | 36,000 | -- | -17,000 | 17,000 |
| Changes In Cash | -439,000 | -259,000 | -721,000 | -2.0M | 3.0M | -- |
| Beginning Cash Position | 808,000 | 1.1M | 1.7M | 3.7M | 656,000 | -- |
| End Cash Position | 351,000 | 808,000 | 1.1M | 1.7M | 3.6M | -- |
| Free Cash Flow | -1.1M | -445,000 | -721,000 | -1.9M | 2.5M | -- |
| Cash From Discontinued Investing Activities | -10,000 | -- | -- | -- | 0.00 | -- |
| Cash From Discontinued Operating Activities | 0.00 | -- | -- | -- | -111,000 | -- |
| Common Stock Issuance | -- | -- | -- | 0.00 | 4.3M | -- |
| Earnings Losses From Equity Investments | 12,000 | 13,000 | 11,000 | 23,000 | 7,000 | -- |
| Long Term Debt Payments | -- | -- | -- | -- | 0.00 | 0.00 |
| Net Business Purchase And Sale | -592,000 | 0.00 | 0.00 | -1.4M | -759,000 | -- |
| Net Foreign Currency Exchange Gain Loss | -- | -- | -- | -- | 27,000 | -27,000 |
| Net Income From Continuing Operations | -640,000 | -595,000 | -796,000 | -8.5M | -1.2M | -- |
| Net Long Term Debt Issuance | -- | -- | -- | -- | 0.00 | 0.00 |
| Net Other Investing Changes | -- | -- | -- | 1.3M | -- | -- |
| Operating Gains Losses | 114,000 | 13,000 | 11,000 | 22,000 | 7,000 | -- |
| Proceeds From Stock Option Exercised | 0.00 | -- | -- | 0.00 | 0.00 | -- |